Andrew Hykes, the CEO of Inari Medical, holds a B.B.A. from the University of Wisconsin Madison and an M.B.A. from Harvard Business School. He has held key positions at Inari Medical, starting as Chief Commercial Officer in 2017 and moving...

Andrew Hykes, the CEO of Inari Medical, holds a B.B.A. from the University of Wisconsin Madison and an M.B.A. from Harvard Business School. He has held key positions at Inari Medical, starting as Chief Commercial Officer in 2017 and moving up to Chief Operating Officer before becoming the CEO in January 2023. His experience in the healthcare sector includes roles at Sequent Medical and Medtronic, where he developed skills in commercial operations, marketing, and regulatory affairs. Under his leadership, Inari Medical has focused on improving patient outcomes and driving innovation in medical technology. In 2023, Hykes received a total compensation of $29.5 million, primarily due to vested stock options and a performance bonus reflecting a strong company performance in revenues and research milestones. He is deeply invested in the company, holding significant shares of Inari Medical stock, aligning his interests with those of shareholders. Beyond his professional life, Hykes is committed to advancing healthcare solutions that can make a real difference in people's lives.